Michelle D Liedtke

Summary

Affiliation: University of Oklahoma Health Sciences Center
Country: USA

Publications

  1. doi request reprint A probable interaction between warfarin and the antiretroviral TRIO study regimen
    Michelle D Liedtke
    Department of Pharmacy, Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
    Ann Pharmacother 46:e34. 2012
  2. doi request reprint Warfarin-antiretroviral interactions
    Michelle D Liedtke
    Department of Pharmacy, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA
    Ann Pharmacother 43:322-8. 2009
  3. doi request reprint Drug interactions with antiretrovirals and warfarin
    Michelle D Liedtke
    Department of Pharmacy, University of Oklahoma, Health Sciences Center, College of Pharmacy, 1110 N Stonewall, CPB 206, Oklahoma City, OK 73117, USA
    Expert Opin Drug Saf 9:215-23. 2010
  4. ncbi request reprint Anticonvulsant and antiretroviral interactions
    Michelle D Liedtke
    Department of Pharmacy, Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA
    Ann Pharmacother 38:482-9. 2004
  5. doi request reprint Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir
    Chris R Rathbun
    Department of Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, USA
    HIV Clin Trials 10:328-36. 2009

Detail Information

Publications5

  1. doi request reprint A probable interaction between warfarin and the antiretroviral TRIO study regimen
    Michelle D Liedtke
    Department of Pharmacy, Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
    Ann Pharmacother 46:e34. 2012
    ..To report a probable drug interaction between the antiretroviral TRIO regimen (ritonavir-boosted darunavir, etravirine, and raltegravir) and warfarin in an HIV-infected patient...
  2. doi request reprint Warfarin-antiretroviral interactions
    Michelle D Liedtke
    Department of Pharmacy, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA
    Ann Pharmacother 43:322-8. 2009
    ..To review the literature for information regarding interactions between warfarin and antiretroviral agents and evaluate the clinical significance of these interactions...
  3. doi request reprint Drug interactions with antiretrovirals and warfarin
    Michelle D Liedtke
    Department of Pharmacy, University of Oklahoma, Health Sciences Center, College of Pharmacy, 1110 N Stonewall, CPB 206, Oklahoma City, OK 73117, USA
    Expert Opin Drug Saf 9:215-23. 2010
    ..Titration of warfarin dose should be conducted on the basis of close monitoring of the international normalized ratio. Empiric warfarin dose modifications should be considered for individual antiretrovirals...
  4. ncbi request reprint Anticonvulsant and antiretroviral interactions
    Michelle D Liedtke
    Department of Pharmacy, Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA
    Ann Pharmacother 38:482-9. 2004
    ..To evaluate the clinical significance of interactions between anticonvulsant and antiretroviral agents and provide recommendations regarding their concurrent use...
  5. doi request reprint Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir
    Chris R Rathbun
    Department of Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, USA
    HIV Clin Trials 10:328-36. 2009
    ..Concurrent atazanavir (ATV) and lopinavir/ritonavir (LPV/r) may be useful for patients with extensive antiretroviral resistance; however, limited information exists concerning the pharmacokinetics and safety of this combination...